FIELD: medicine.
SUBSTANCE: invention relates to a method for treating cancer in a person in need thereof. The method includes detecting a mutant BTK in a sample from a person, wherein the mutant BTK includes a C481S mutation; administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof when a mutant BTK is detected.
EFFECT: new method of treatment based on a compound of formula (I) or a pharmaceutically acceptable salt thereof, which can be used in medicine.
15 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS FOR USE THEREOF | 2015 |
|
RU2715421C2 |
| 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE | 2018 |
|
RU2795850C2 |
| COMPOSITIONS AND METHODS WHICH CAN BE USED FOR TREATING PROLIFERATIVE DISEASES | 2015 |
|
RU2711500C2 |
| COMPOUND BASED ON PYRROLAMIDOPYRIDONE, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2809596C2 |
| QUINAZOLINONE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2017 |
|
RU2730500C2 |
| BTK INHIBITORS | 2020 |
|
RU2830171C1 |
| HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION | 2016 |
|
RU2744897C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING PROSTATE CANCER, USING BENZOHETEROCYCLIC COMPOUND AND METHOD FOR PREVENTING AND/OR TREATING PROSTATE CANCER | 2016 |
|
RU2705576C2 |
| PURIFIED PYRROLOQUINOLINYL-PYRROLIDINE-2,5-DIONE COMPOSITIONS AND METHODS OF OBTAINING AND APPLICATION THEREOF | 2010 |
|
RU2556205C2 |
| COMBINATION, USE THEREOF AND METHOD OF TREATING | 2017 |
|
RU2731535C1 |
